Table 3 Total bone mineral density (BMD) score at L-spine and FRAX® score for major osteoporotic and hip fractures.

From: Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study

Variable

Time

CAB group (N = 234)

GnRH group (N = 70)

Difference 95% C.I.

Between groups p-value¤

Total bone marrow density (BMD) score at L-spine

Changes in total BMD score

 

n

Mean ± SD

n

Mean ± SD

  

Baseline

223

1.16 ± 0.25

63

1.15 ± 0.22

 

0.8636§

12 Month

184

1.13 ± 0.26

55

1.09 ± 0.19

  
 

176

−0.04 ± 0.14

48

−0.05 ± 0.06

0.01 (−0.03, 0.06)

0.4887§

Within group p-value

0.0009§§

 

<0.0001§§

   

Rate of BMD change

 

176

−2.61 ± 13.11

48

−4.37 ± 5.04

1.77(−2.04, 5.57)

0.1518§

Within group p−value

0.0090§§

 

<0.0001§§

   

FRAX ® score of major osteoporotic and hip fractures

Major osteoporotic fracture (%)

Baseline

234

5.08 ± 3.14

70

5.35 ± 2.75

 

0.5194§

12 month

186

4.96 ± 2.84

55

5.85 ± 3.48

  

change

186

−0.23 ± 2.79

55

0.20 ± 2.74

 

0.3189§

Within group p-value

0.2635§§

 

0.5973§§

   

Hip fracture (%)

Baseline

234

1.50 ± 1.54

70

1.87 ± 1.78

 

0.0943§

12 month

186

1.69 ± 1.76

55

2.41 ± 2.53

  

change

186

0.20 ± 1.16

55

0.36 ± 1.97

 

0.5531§

Within group p-value

0.0231§§

 

0.1798§§§

   
  1. Change = score at 12 month − score at baseline Rate of BMD change = (BMD score at 12 month − BMD score at baseline)/BMD score at baseline ×100 Difference = CAB group − GnRH group ¤p-value of difference between groups (CAB group − GnRH group): §Two sample t-test §§Paired t-test.